FDA's Enforcement Priorities Likely To Change In 2017 And Other "Unknowable Knowns"

ß

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

This post will outline some of our thoughts related to what could face FDA and its various stakeholders as we go forward into the great unknown.